Elad Sharon: I am ecstatic to announce that I am joining Dana-Farber as the Clinical and Translational Director of the iTOX Service.
Quoting Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, on X/Twitter:
”I am ecstatic to announce that I am joining Dana-Farber as the Clinical and Translational Director of the iTOX Service. I am proud of all we have been able to accomplish for patients utilizing the tools of immunotherapy from my time National Cancer Institute & I will continue drug dev efforts!
Monica M. Bertagnolli is an exceptional leader! Collaboratively with NCI Center for Cancer Research, NCI CTEP Clinical Research, NCI Cancer Stats & others, I hope I can continue to contribute to this incredible field with my academic, pharmaceutical, FDA Oncology, and National Cancer Institute colleagues!
We are in an amazing time for cancer research and innovation. To reach cancer moonshots, cancer ground shots & more, we must redouble our efforts, we must leave no patients behind and we must learn from every patient and every experience!
My incredible colleagues from Dana-Farber have been so supportive in this transition! I feel lucky to be joining this group and I feel we can achieve great things together!”
-
17:28 29/11JeeSuk Chang: A multi-center trial - great efforts from the KROG team
-
17:00 29/11Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
-
23:17 28/11Manni Mohyuddin: Current trials must have observation/surveillance as control arm
-
23:04 28/11Juan P. Alderuccio: Our approach to secondary CNS involvement by aggressive lymphomas
-
17:17 27/11Vivek Subbiah: Treatment patterns and overall survival (OS) in patients with advanced NSCLC in three countries between 2011 and 2020
-
17:43 28/11Michele Carbone: The world is full of good, honest, nice people
-
17:24 28/11Jessica Clerc: Celebrating 90 Years of Excellence and Dedication in Cancer Care!
-
17:44 25/11Carlos Pedraz: Congratulations, Dr. Rafael Rosell for the very well deserved 2023 ISLB Lifetime Achievement Award
-
17:10 25/11100 Influential Celebrities in Oncology: The 2023 Edition – Part 4
-
13:34 24/11"Bald for a Cause" initiative - UWC Dilijan College
-
17:34 28/11The International Association of Cancer Registries annual conference - IARC
-
18:05 26/11Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
17:58 26/11Lisa A. Lacasse: My sincere gratitude to the ACS CAN team, our incredible volunteers, and supporters for another outstanding year
-
16:47 16/11How social determinants can influence a patient’s ability to stay in treatment - ASCO
-
13:22 16/11SIOP Europe Student Summer School for Paediatric Oncology
-
17:25 29/11NIH Director’s Early Independence Award supports junior scientists to launch independent careers - National Cancer Institute
-
17:07 29/11Santhosh Kumar Devadas: I’m starting a new position as a Professor of Medical Oncology and Chief of Bone Marrow Transplant at Ramaiah Memorial Hospital and Ramaiah Medical College
-
16:48 27/11CRCHD seeks motivated scientists to serve as Program Directors - NCI Disparities
-
16:25 27/11Luisa Basset completed a fruitful nine-year tenure on the CCI board of trustees - Childhood Cancer International
-
18:14 26/11Tristan Knight: Attention hematology / oncology and pediatric hematology / oncology fellows